CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $65,000 | -82.3% | 11,261 | -78.5% | 0.00% | -84.6% |
| Q1 2021 | $368,000 | -89.8% | 52,396 | -74.0% | 0.03% | -87.1% |
| Q4 2018 | $3,614,000 | +99.3% | 201,218 | +939.3% | 0.20% | +176.7% |
| Q2 2017 | $1,813,000 | -59.9% | 19,361 | -72.7% | 0.07% | -69.2% |
| Q1 2017 | $4,524,000 | +44.7% | 71,047 | +109.0% | 0.24% | +238.6% |
| Q3 2015 | $3,126,000 | +57.8% | 33,997 | +4.3% | 0.07% | +29.6% |
| Q3 2013 | $1,981,000 | – | 32,596 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |